Applied DNA Rebrands as BNB Plus Corp., Elects Josh Kruger as Chairman of the Board

Applied DNA Sciences, Inc. (NASDAQ: BNBX) (the “Company”) today announced that it will change its name to BNB Plus Corp. (“BNB Plus”), reflecting the Company's commitment to delivering a yield-optimized, BNB-based digital asset treasury strategy leveraging the Binance ecosystem. Alongside the rebrand, the Company also announced the appointment of Josh Kruger as Chairman of the Board.

Mr. Kruger has deep expertise in managing blockchain-native assets for yield and capital efficiency. He is the founder of OnChain Alpha and previously served as Head of Trading at Coral Capital, which was acquired by DNA Fund in late 2024.

As part of the leadership transition, Judy Murrah has voluntarily stepped down as Chairperson of the Board and will continue to serve as a Director.

“Josh’s appointment signals our commitment to strengthening our DeFi leadership as we enter our next phase of growth,” said Clay Shorrock, CEO and President of BNB Plus. “We believe his deep expertise in sophisticated yield-generation strategies will prove instrumental as we expand our BNB holdings and execute our planned accretive yield model.”

“I’m excited to serve as Chairman during this transformative chapter for the Company,” said Josh Kruger, Chairman of the Board. “BNB Plus is building a bold financial architecture rooted in Binance-native tools, and I look forward to working with the team to drive disciplined execution and unlock new forms of shareholder value.”

Following its recent ticker change to BNBX, the Company initiated a formal rebranding process to BNB Plus, including the development of its soon-to-be launched website BNB.plus and additional investor materials. Further updates will be shared as the transition progresses.

About BNB Plus Corp.

BNB Plus is unlocking institutional-grade access to the Binance ecosystem, delivering non-directional yield strategies and long BNB exposure, powering the future of blockchain through a transparent, actively managed BNB treasury. The Company’s differentiated strategy blends sophisticated DeFi yield generation with Binance-native opportunities, unlocking access to high-performance digital assets for investors traditionally excluded from the space. Formally Applied DNA Sciences, Inc., BNB Plus continues to commercialize proprietary nucleic acid production solutions for the biopharmaceutical and diagnostics markets.